Dog PMBCs with natural Trypanosoma cruzi infection and therapeutic vaccine
As part of the development of an immunotherapeutic vaccine against Trypanosoma cruzi infection, we assessed the transcriptomic response of PBMCs from dogs with natural T. cruzi infection, treated or not with a therapeutic vaccine based on Tc24 and TSA1 recombinant antigens.